NEWS
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC
Thursday, 17th April at 4:45 pm
Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025
Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025
SAN MATEO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (NASDAQ: VINC) today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission ("SEC") on or about April 28, 2025, which will remove Vincerx's common stock from listing and registration on The Nasdaq Stock Market ("Nasdaq").
On April 14, 2025, Vincerx received written notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of its common stock for the prior 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share (the "Delisting Notice"). Vincerx is not eligible for any compliance period and as a result, Nasdaq provided notice that it will suspend the trading of Vincerx's common stock at the opening of business on April 23, 2025 and that a Form 25 will be filed.
Vincerx's board of directors determined that it would be in the best interests of its stockholders to dissolve, liquidate, and wind-up its business and affairs and distribute to stockholders any assets remaining after paying or providing for payment of its creditors. Given this, Vincerx does not intend to appeal the Nasdaq determination. Vincerx intends to voluntarily file a Form 25 to delist and deregister its common stock. Vincerx does not intend to make arrangements to list its common stock on another national securities exchange or other market.
Once the Form 25 becomes effective, Vincerx intends to file a Form 15 to deregister with the SEC.
Thursday, 17th April at 4:45 pm
Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025
Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025
SAN MATEO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (NASDAQ: VINC) today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission ("SEC") on or about April 28, 2025, which will remove Vincerx's common stock from listing and registration on The Nasdaq Stock Market ("Nasdaq").
On April 14, 2025, Vincerx received written notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of its common stock for the prior 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share (the "Delisting Notice"). Vincerx is not eligible for any compliance period and as a result, Nasdaq provided notice that it will suspend the trading of Vincerx's common stock at the opening of business on April 23, 2025 and that a Form 25 will be filed.
Vincerx's board of directors determined that it would be in the best interests of its stockholders to dissolve, liquidate, and wind-up its business and affairs and distribute to stockholders any assets remaining after paying or providing for payment of its creditors. Given this, Vincerx does not intend to appeal the Nasdaq determination. Vincerx intends to voluntarily file a Form 25 to delist and deregister its common stock. Vincerx does not intend to make arrangements to list its common stock on another national securities exchange or other market.
Once the Form 25 becomes effective, Vincerx intends to file a Form 15 to deregister with the SEC.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
13K
Followers
65
Following
174K
Visitors
Follow
ReoNnA : sayonara $Vincerx Pharma (VINC.US)$